1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 11 MAY 2015

Cancer Drug News 11 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Diversification To Bolster Celgene's Revenues
Industry Brief - Roche's Venetoclax Gains FDA Breakthrough Therapy Designation
Industry Trend Analysis - Zykadia Will Not Surpass Xalkori Without First-Line Approval
Industry Brief - ESSA's IND Application For EPI-506 Placed On Clinical Hold By FDA
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For Gastric Cancers
Industry Brief - Baxter Seeks EU Approval For MM-398 In Post-Gemcitabine MPC
Industry Brief - Can-Fite's CF102 Phase II HCC Trial Approved In Europe
Industry Trend Analysis - CytRx' Outperformance To Continue
Industry Brief - Plexxikon/Merck Collaborate On PLX3397/Keytruda Combination Trial
Industry Brief - COT Granted European Patent Covering COTI-2
Industry Brief - Qu Biologics Granted EU Patent Covering Use Of Bacterial Compositions In Cancer
Industry Brief - Acacia Reports Positive Results From Phase II Study With APD403 In CINV
Industry Brief - FDA Grants Fast Track Designation To Sucampo's Cobiprostone
Industry Trend Analysis - EpiTherapeutics Acquisition Will Be Start Of Oncology Deals For Gilead In 2015

Table Of Contents

Cancer Drug News 11 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Breast Cancer Statistics in Africa

  • December 2016
    14 pages
  • Breast Cancer  

  • Africa  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.